Latest & greatest articles for statin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on statin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on statin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for statin

1. The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs Full Text available with Trip Pro

The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need

2021 NIHR HTA programme

2. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study Full Text available with Trip Pro

therapy* Actions COVID-19 / mortality* Actions Case-Control Studies Actions Cohort Studies Actions Comorbidity Actions Denmark / epidemiology Actions Female Actions Humans Actions Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Actions Male Actions Middle Aged Actions Pandemics Actions Proportional Hazards Models Actions Registries Actions Risk Factors Actions SARS-CoV-2 Actions Severity of Illness Index Actions Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors Actions (...) Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly

2021 EvidenceUpdates

3. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis

Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID (...) : 10.1001/jamainternmed.2020.6084. Online ahead of print. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Geriatrics and Gerontology, School of Medicine, University of California, San Diego. 2 Geriatrics, Palliative and Extended Care Service Line, San Francisco VA (Veterans Affairs) Health Care System, San Francisco, California. 3 Division

2020 EvidenceUpdates

4. Add a fibrate to a statin?

Add a fibrate to a statin? Add a fibrate to a statin? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Add a fibrate to a statin? View/ Open Date 2010-10 Format Metadata Abstract Do not routinely add a fibrate to a statin for patients with type 2 diabetes who are at high risk for cardiovascular events. Stength

2020 PURLS

5. Efficacy of statins in the prevention of epilepsy: a systematic review and meta-analysis of cohort studies Full Text available with Trip Pro

Efficacy of statins in the prevention of epilepsy: a systematic review and meta-analysis of cohort studies Inplasy Protocol 813 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

6. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia. (Abstract)

Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia. Strategies to improve patients' tolerance of and adherence to statins may enhance the effectiveness of dyslipidemia treatment in those at risk for cardiovascular disease (CVD).To assess the benefits and harms of interventions to improve statin (...) adherence in patients at risk for CVD.MEDLINE, EMBASE, PubMed, and the Cochrane Library from December 2013 through May 2019 (English language only).Systematic reviews (SRs), randomized controlled trials (RCTs), and cohort studies that addressed interventions for improving statin tolerance and adherence.One investigator abstracted data and assessed study quality, and a second investigator checked abstractions and assessments for accuracy.One SR, 1 RCT, and 4 cohort studies were included. The SR found

2020 Annals of Internal Medicine

7. The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation: a protocol for systematic review and network meta-analysis Full Text available with Trip Pro

The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation: a protocol for systematic review and network meta-analysis Inplasy Protocol 732 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

8. In patients with ASCVD and elevated LDL-C with maximal statin therapy, inclisiran reduced LDL-C levels at 18 months. (Abstract)

In patients with ASCVD and elevated LDL-C with maximal statin therapy, inclisiran reduced LDL-C levels at 18 months. Ray KK, Wright RS, Kallend D, et al. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med. 2020;382:1507-19. 32187462.

2020 Annals of Internal Medicine

9. Comparative efficacy of statin and antihypertensive agent combinations: a network meta-analysis of randomized controlled trials v1 (protocols.io.bjxekpje) Full Text available with Trip Pro

Comparative efficacy of statin and antihypertensive agent combinations: a network meta-analysis of randomized controlled trials v1 (protocols.io.bjxekpje) Comparative efficacy of statin and antihypertensive agent combinations: a network meta-analysis of randomized controlled trials protocols.io

2020 protocols.io

10. Statins for asthma. (Abstract)

Statins for asthma. Asthma is a common chronic respiratory disease. People with asthma have inflammation of their airways that causes recurrent episodes of wheezing, breathlessness and chest tightness, with or without a cough. Statins possess multiple therapeutic effects, including lowering lipid levels in the blood. Statins are reported to have a potential role as an adjunct treatment in asthma. However, comprehensive evidence of the benefits and harms of using statins is required (...) to facilitate decision making.To assess the benefits and harms of statins as an adjunct therapy for asthma in adults and children.We searched for studies in the Cochrane Airways Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE Ovid SP and Embase Ovid SP, from their inception dates We handsearched the proceedings of major respiratory conferences. We also searched clinical trials registries for completed, ongoing and unpublished studies, and scanned the reference lists

2020 Cochrane

11. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Stroke Actions . 2020 May;51(5):1546-1554. doi: 10.1161/STROKEAHA.119.027759. Epub 2020 Apr 21. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis , , , , , , , , , , , , Affiliations Expand

2020 EvidenceUpdates

12. Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National (...) of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Thromb Haemost Actions . 2020 May;120(5):866-875. doi: 10.1055/s-0040-1709711. Epub 2020 May 5. Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis , , , , , , Affiliations Expand Affiliations 1 Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Italy. 2 Department

2020 EvidenceUpdates

13. Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Full Text available with Trip Pro

Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square (...) does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Xian Yang, Xi Lan, Xin-Lin Zhang, Zhong-Lin Han, Si-Min Yan, Wen-Xiao Wang, Biao

2020 Research Square

14. PCSK9 Inhibitors and Ezetimibe Monotherapy In Patients Not Receiving Statin Therapy: A Meta-analysis of Randomized Trials Full Text available with Trip Pro

PCSK9 Inhibitors and Ezetimibe Monotherapy In Patients Not Receiving Statin Therapy: A Meta-analysis of Randomized Trials PCSK9 Inhibitors and Ezetimibe Monotherapy In Patients Not Receiving Statin Therapy: A Meta-analysis of Randomized Trials | Morressier We use cookies to ensure that we give you the best experience on our website Got it Signup Login Home Saved research Copy DOI Download Submission PCSK9 Inhibitors and Ezetimibe Monotherapy In Patients Not Receiving Statin Therapy: A Meta (...) -analysis of Randomized Trials Submitted May 29, 2020 26 Views 0 Downloads 0 Saves Video PDF Abstract 0 Datasets Presented at Jun 5, 2020 Presentation Download Abstract Statins are the mainstay of treatment for LDL lowering , however, some patients cannot tolerate statins because of statin-associated muscle symptoms. Ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) are alternative treatments for them. The purpose of this meta-analysis is to compare LDL reduction with PCSK9 inhibitors

2020 Morressier

15. Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis Full Text available with Trip Pro

Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis EISSN 2148-5607 Turkish Journal of Gastroenterology Toggle navigation Turkish Journal of Gastroenterology HIGHLY CITED ARTICLES By: Aydin, M. Merve; Akcali, Kamil Can By: Besheer, Tarek; Arafa, Mona M.; Abd El-Maksoud, Mohamed; et al (...) . By: Yilmaz, Ilkay; Dolar, M. Enver; Ozpinar, Haydar By: Demir, Meryem; Deyneli, Oguzhan; Yilmaz, Yusuf By: Tozlu, Mukaddes; Kayar, Yusuf; Ince, Ali Tuzun; et al. By: Bashiri, Mehrnoosh; Akcali, Didem; Coskun, Demet; et al. Statins in hepatitis B or C pa... Original Article Statins in hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis , , , , , , , 1. Department of Gastroenterology and Hepatology, Dongzhimen Hospital affiliated

2020 The Turkish Journal of Gastroenterology

16. Is There a Role For Statin Therapy in Acute Viral Infections?

Is There a Role For Statin Therapy in Acute Viral Infections? Is There a Role For Statin Therapy in Acute Viral Infections? - American College of Cardiology ') Search All Types Search or Menu Accessed 3/14/2020 Share via: Clinical Topics: Keywords: Cardiology Magazine, ACC Publications, Coronavirus, COVID-19, Pneumonia, Ventilator-Associated, Influenza, Human, Cardiovascular Diseases, Outpatients, Coronavirus Infections, Primary Prevention, Atherosclerosis, Orthomyxoviridae, Pneumonia (...) , Bacterial, Diabetes Mellitus, Rhabdomyolysis, Administration, Oral, Anti-Inflammatory Agents > > Is There a Role For Statin Therapy in Acute Viral Infections? Heart House 2400 N Street NW Washington, DC 20037 Phone: , ext. 5603 or , ext. 5603 E-mail: Fax: (202) 375-7000 © 2020 American College of Cardiology Foundation. All rights reserved.

2020 American College of Cardiology

17. Associations between statin use and osteoarthritis risk and progression: a systematic review and meta-analysis Full Text available with Trip Pro

Associations between statin use and osteoarthritis risk and progression: a systematic review and meta-analysis Inplasy Protocol 182 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

18. Effects of statins on lipid profile of kidney transplant recipients: a meta-analysis of randomized controlled trials Full Text available with Trip Pro

Effects of statins on lipid profile of kidney transplant recipients: a meta-analysis of randomized controlled trials Effects of statins on lipid profile of kidney transplant recipients: a meta-analysis of randomized controlled trials | medRxiv Search for this keyword Effects of statins on lipid profile of kidney transplant recipients: a meta-analysis of randomized controlled trials Xiu Huang , Yong Jia , Xiaoyu Zhu , Yangyang Zhang , Lili Jiang , Xuejiao Wei , Dan Zhao , Xiaoxia Zhao , Yujun Du (...) To assess the benefits of statins on lipid profile in kidney transplant recipients via a meta-analysis. Methods We systematically identified peer-reviewed clinical trials, review articles, and treatment guidelines from PubMed, Embase, the Cochrane Library, Wanfang, Chinese National Knowledge Infrastructure (CNKI), SinoMed (CBM), and Chongqing VIP databases from inception to April 2019. In the analysis, only randomized controlled clinical trials performed in human were included. Results Eight articles

2020 Cold Spring Harbor Laboratory

19. Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Full Text available with Trip Pro

Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square (...) does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Intensive versus non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: a meta-analysis of randomized controlled trials Xian Yang, Xi Lan, Xin-Lin Zhang, Zhong-Lin Han, Si-Min Yan, Wen-Xiao Wang, Biao

2020 Research Square

20. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. Full Text available with Trip Pro

Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. Preclinical and epidemiological studies indicate a potential chemopreventive role of statins in epithelial ovarian cancer risk.To evaluate the association of genetically proxied inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ie, genetic variants related to lower function of HMG-CoA reductase, target of statins) with epithelial ovarian cancer among the general (...) population and in BRCA1/2 mutation carriers.Single-nucleotide polymorphisms (SNPs) in HMGCR, NPC1L1, and PCSK9 associated with low-density lipoprotein (LDL) cholesterol in a genome-wide association study (GWAS) meta-analysis (N ≤196 475) were used to proxy therapeutic inhibition of HMG-CoA reductase, Niemann-Pick C1-Like 1 (NPC1L1) and proprotein convertase subtilisin/kexin type 9 (PCSK9), respectively. Summary statistics were obtained for these SNPs from a GWAS meta-analysis of case-control analyses

2020 JAMA